GLOW Blend Overview

The GLOW Blend combines three synthetic peptides studied for their roles in cellular regeneration and repair processes: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic repair pathways. In laboratory and preclinical models, the combination provides a platform for exploring synergistic effects in tissue integrity, vascular regulation, and cellular recovery.

Pickart L. et al. (2015)

History

The concept of the GLOW Blend arises from decades of research into individual regenerative peptides. GHK-Cu was first identified in human plasma in the 1970s and later studied for gene regulation and tissue repair activity. BPC-157 was synthesized in the 1990s as a gastric protein fragment analog and has since been researched for angiogenic and reparative processes. TB-500, derived from thymosin beta-4, traces its research lineage to thymus peptide studies in the 1960s and is recognized for its effects on cellular migration and angiogenesis. Combined, these peptides represent a convergence of regenerative research lines.

Sikiric P. et al. (1993)

GHK-Cu Structure

CAS #: 49557-75-7

Molecular Formula: C₁₄H₂₄CuN₆O₄

Molecular Weight: 340.9 g/mol

PubChem ID: 5311476

BPC-157 Structure

CAS #: 137525-51-0

Molecular Formula: C₁₄H₂₄CuN₆O₄

Molecular Weight: 340.9 g/mol

PubChem ID: 5311476

TB-500 Structure

CAS #: 77591-33-4

Formula: C₂₁₂H₃₅₀N₅₆O₇₈S

Molecular Weight: 4963.5 g/mol

PubChem ID: 16132321

Research Findings

The GLOW Blend, which combines GHK-Cu, BPC-157, and TB-500, has been studied across structural, dermatological, vascular, and systemic models. Research highlights its activity in collagen organization, wound closure, angiogenesis, and cellular protection. Together, these peptides complement one another by engaging pathways linked to tissue repair, regeneration, and resilience in preclinical settings.

Key Areas of Research:

• Structural: collagen, matrix, tendon/ligament

• Dermatological: wound closure, skin, hair growth

• Vascular: angiogenesis, nitric oxide, vessels

• Systemic: protection, recovery, viability

Together, these findings suggest broad experimental potential for the GLOW Blend across multiple biological pathways. By combining structural support, vascular regulation, and dermatological repair with systemic protection, the GLOW Blend provides a versatile platform for research into regeneration, tissue recovery, and overall biological resilience in laboratory models.

Pickart L. et al., 2015

References

Pickart L. et al. (2015). GHK-Cu and regulation of multiple biological processes in aging and repair. BioMed Res Int.

Sikiric P. et al. (1993). A new gastric peptide, BPC-157, characterized and synthesized. Peptides, 14(1): 127–131. 

Goldstein A.L. et al. (2005). Thymosin beta-4 and tissue regeneration: potential mechanisms of action. Ann N Y Acad Sci.

Maquart F.X. et al. (1988). Stimulation of collagen synthesis by the tripeptide GHK in fibroblast cultures. FEBS Lett, 238(2):343–346.

Japjec M. et al. (2021). BPC-157 and tendon/ligament structural integrity in experimental models. Int J Mol Sci, 22(17):9397.

Smart N. et al. (2007). Thymosin beta-4 induces progenitor mobilization and neovascularization. Nature, 445(7124):177–182.

Philp D. et al. (2003). Thymosin beta-4 promotes dermal wound healing. J Invest Dermatol, 121(4):694–701. 

Hsieh M.J. et al. (2014). Pro-angiogenic and reparative effects of BPC-157 in preclinical models. J Mol Med, 92(5): 483–495.

Bock-Marquette I. et al. (2004). Thymosin beta-4 activates integrin-linked kinase and promotes cardiac repair. Nature, 432(7016):466–472.

Kang E.A. et al. (2020). BPC-157 protective effects on liver, kidney, and lung in ischemia–reperfusion injury. Int J Mol Sci, 21(12): 4232.